middle.news
Optiscan Expands Clinical Trials with US Head and Neck Cancer Study
8:21am on Tuesday 1st of September, 2026 AEST
•
Healthcare
Read Story
Optiscan Expands Clinical Trials with US Head and Neck Cancer Study
8:21am on Tuesday 1st of September, 2026 AEST
Key Points
New 35-patient US study on head and neck cancer initiated
Focus on real-time surgical margin assessment with InVue™ and InForm™
Collaboration with Mayo Clinic to generate data for FDA filings
Study explores both in vivo and ex vivo imaging workflows
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Optiscan Imaging (ASX:OIL)
OPEN ARTICLE